Index by author
January 2025; Volume 45,Issue 1
Abdulahi, HASSAN
- You have accessDoes Low-grade Follicular Lymphoma With a High Proliferation Index Require a Different Treatment Strategy? A Single Center ExperienceRAHIM A. JIWANI, EIRAJ KHAN, HASSAN ABDULAHI, URWAT VUSQA, CYRUS KHAN and YAZAN SAMHOURIAnticancer Research January 2025, 45 (1) 225-228; DOI: https://doi.org/10.21873/anticanres.17408
Abe, KYOHEI
- You have accessLipoprotein(a) as a Predictor of Nonalcoholic Fatty Liver After PancreatectomyKYOHEI ABE, SHUICHI FUJIOKA, YUKI TAKANO, YOSHIHIRO SHIRAI, MASASHI TSUNEMATSU, MICHINORI MATSUMOTO, KENEI FURUKAWA, KOICHIRO HARUKI, SHINJI ONDA and TORU IKEGAMIAnticancer Research January 2025, 45 (1) 287-293; DOI: https://doi.org/10.21873/anticanres.17416
Aiba, TOSHIKI
- Open AccessPrognostic Significance of Plasma Soluble IL-6 Receptor in Carbon-ion Radiotherapy for Pancreatic CancerKAZUTAKA DOI, MAKOTO SHINOTO, TETSURO ISOZAKI, TAKASHI IMAI, TOSHIKI AIBA, SUMITAKA HASEGAWA and TSUGUHIDE TAKESHIMAAnticancer Research January 2025, 45 (1) 209-217; DOI: https://doi.org/10.21873/anticanres.17406
Aisaka, AOI
- You have accessHederagenin Glycoside Isolated from the Pericarps of Akebia quinata Fruits Induces Apoptotic Cell Death in Breast Cancer CellsAKIRA SATO, SAKURA MASAKA, AOI AISAKA, IKUTO ISHIBASHI, AYANO YABUKI, HINA NEMOTO, MAKOTO OHIRA, MASANORI YAMAURA, KATSUHIKO SUZUKI, KEIICHI MATSUZAKI, TSUKASA MATSUMOTO and YASUSHI KAWASAKIAnticancer Research January 2025, 45 (1) 135-144; DOI: https://doi.org/10.21873/anticanres.17400
An, XIAOYU
- Open AccessEribulin Induction of Immunogenic Cell Death (ICD): Comparison With Other Cytotoxic Agents and Temporal Relationship of ICD BiomarkersMINGFA ZANG, JIA ZHENG, XIAOYU AN, BO LI, HUAJUN YANG, BRIAN ERICKSON, RYAN KUNZ and BRUCE A. LITTLEFIELDAnticancer Research January 2025, 45 (1) 39-53; DOI: https://doi.org/10.21873/anticanres.17391
Ansari, AMIR
- You have accessThe Challenge of Diagnosing Acute Myeloid Leukemia or Blastic Plasmacytoid Dendritic Cell Neoplasm: A Case ReportSAHIL GARG, AMOL DUA, AMIR ANSARI and IMAD TABBARAAnticancer Research January 2025, 45 (1) 229-233; DOI: https://doi.org/10.21873/anticanres.17409
Arai, KEISUKE
- You have accessTreatment Outcomes of Tyrosine Kinase Inhibitors and Durvalumab Plus Tremelimumab After Atezolizumab Plus Bevacizumab for Hepatocellular CarcinomaNOBUAKI ISHIHARA, SHOHEI KOMATSU, YOSHIHIKO YANO, YOSHIMI FUJISHIMA, JUN ISHIDA, MASAHIRO KIDO, HIDETOSHI GON, KENJI FUKUSHIMA, TAKESHI URADE, TOSHIHIKO YOSHIDA, KENTARO TAI, KEISUKE ARAI, HIROAKI YANAGIMOTO, HIROCHIKA TOYAMA, TAKANORI MATSUURA, TOSHIFUMI TADA, YUZO KODAMA and TAKUMI FUKUMOTOAnticancer Research January 2025, 45 (1) 251-260; DOI: https://doi.org/10.21873/anticanres.17412
Arya, SHAHRZAD
- Open AccessHow to Predict Recurrence After Resection of Hepatocellular CarcinomaNATALIE PETRUCH, LOUISA BOLM, MARTINA NEBBIA, SHAHRZAD ARYA, MARCO VENTIN, MOTAZ QADAN, NAHEL ELIAS, JANNIS DUHN, DIRK RADES, LEIGH A. DAGEFORDE, KENNETH T. TANABE, JOSEPH FRANSES, VIKRAM DESHPANDE, ULRICH F. WELLNER, TOBIAS KECK, ONOFRIO CATALANO and CRISTINA R. FERRONEAnticancer Research January 2025, 45 (1) 189-199; DOI: https://doi.org/10.21873/anticanres.17404
Asuka, SANO
- You have accessComparing Immuno-oncology Combination Therapy With Tyrosine Kinase Inhibitor Monotherapy for Advanced Renal Cell CarcinomaGAKU ISHIKAWA, KEITA TAMURA, YOSHIHIRO TSUCHIYA, SHUNSUKE WATANABE, TAKEMURA AYANA, SANO ASUKA, KYOHEI WATANABE, HIROMITSU WATANABE, YUTO MATSUSHITA, DAISUKE MOTOYAMA, ATSUSHI OTSUKA and TERUO INAMOTOAnticancer Research January 2025, 45 (1) 379-386; DOI: https://doi.org/10.21873/anticanres.17426
Athanasiou, GEORGE
- You have accessElimination of High-grade Gliomas Through Induced Cytolysis, Elucidated by Two Patient CasesCHRISTOS PANOTOPOULOS, GEORGE ATHANASIOU, STAVROS STAVROPOULOS, NICK BOUTOS, SHAILESH RAO, GEORGE PANAYOTOU, NEELAM K. VENKATARAMANA and GUNNAR RONQUISTAnticancer Research January 2025, 45 (1) 201-207; DOI: https://doi.org/10.21873/anticanres.17405